Home > Compound List > Product Information
Aprepitant_Molecular_structure_CAS_170729-80-3)
Click picture or here to close

Aprepitant

Catalog No. A729800 Name Toronto Research Chemicals
CAS Number 170729-80-3 Website http://www.trc-canada.com
M. F. C23H21F7N4O3 Telephone +1 (416) 665-9696
M. W. 534.4266624 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage -20°C Freezer Chembase ID: 72569

SYNONYMS

IUPAC name
3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one
IUPAC Traditional name
aprepitant
Synonyms
MK 869
Emend
ONO 7436
L 754030
5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
MK 0869

DATABASE IDS

CAS Number 170729-80-3

PROPERTIES

Certificate of Analysis Download
Apperance White to Off-White Solid
Melting Point 244-246°C
Solubility Chloroform
Solubility Methanol
MSDS Link Download
Storage Condition -20°C Freezer

DETAILS

Description (English)
A novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolised primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2E

REFERENCES

  • Hale, J.J., et al.: J. Med. Chem., 41, 4607 (1998)
  • Campos, D., et al.: J. Clin. Oncol., 19, 1759 (1998)
  • Van Belle, S., et al.: Cancer, 94, 3032 (1998)
  • Majumdar, A.K., et al.: J. Clin. Pharmacol., 46, 291 (1998)